(NewsDirect)
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF)CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss thecompany's strong position on the Globe and Mail's Report onBusiness annual list of Canada’s top-growing companies.
The company placed 151 out of 425, with athree-year growth rate of 322%.
Saviuk explained that the rankings are calculated on revenuegrowth, and the exponential growth in the company's Enerzairasthma therapy helped it secure its position. Despite launching lessthan two years ago, he said Enerzair and Atectura account for one outof every five new prescriptions.
Given the current trajectory, Saviuk said the company may rankeven higher in 2024.
The Report onBusiness magazine launched Canada’s Top Growing Companies ranking in2019 and companies have to complete an in-depth application processand fulfill certain requirements in order to be recognized.
Valeo Pharma is a fast-growing Canadian pharmaceutical companydedicated to the commercialization of innovative prescription productsin Canada with a focus on Respiratory/Allergy, Ophthalmology andHospital Specialty Products.
ContactDetails
Proactive
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.